Observations placeholder
Leustatin
Identifier
019257
Type of Spiritual Experience
Number of hallucinations: 3
Background
A description of the experience
Cladribine (trade names Leustatin, Litak and Movectro) is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis) and multiple sclerosis. Its chemical name is 2-chlorodeoxyadenosine (2CDA).
As a purine analog, it is a synthetic anti-cancer agent that also suppresses the immune system. Chemically, it mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase, which interferes with the cell's ability to process DNA.
On Jan, 2, 2016: 426 people reported to have side effects when taking Leustatin. Among them, 3 people (0.70%) have Hallucination.
Time on Leustatin when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Jan, 2, 2016: 426 people reported to have side effects when taking Leustatin. Among them, 5 people (1.17%) have Death.
Time on Leustatin when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |